Clinical Medicine

TID:  1 001 VID:  9 MeSH ID:  D015510 Mesh Name:  Clinical Medicine

New Multiple Sclerosis Drug, Backed by 40 Years of Research, Could Halt Disease

A newly approved drug that is the first to reflect the current scientific understanding of multiple sclerosis is holding new hope for the hundreds of thousands Americans living with the disease. It also highlights the importance of clinician scientists like UCSF’s Stephen Hauser who are working to transform research into cures for patients.

$85 Million Grant Supports UCSF Clinical and Translational Science Institute

UC San Francisco’s Clinical and Translational Science Institute (CTSI) has received $85 million over five years from the National Institutes of Health (NIH) to continue to provide training, research support and other services, and to launch new programs aimed at diversifying the patients in research and advancing precision medicine.

Pages